Erivedge Alternatives Compared
| Erivedge (vismodegib) | Fluorouracil topical | Imiquimod topical |
|
|---|
| Erivedge (vismodegib) | Fluorouracil topical | Imiquimod topical |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Basal Cell Carcinoma. Erivedge may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Actinic Keratosis, Basal Cell Carcinoma, Warts, Skin Cancer, Keratosis. Fluorouracil topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Basal Cell Carcinoma, Keratosis, Human Papilloma Virus, Condylomata Acuminata, Molluscum Contagiosum. Imiquimod topical may also be used for purposes not listed in this medication guide. View more |
Related suggestions Basal Cell Carcinoma
|
|||||||||||||||||||||||
| More about Erivedge (vismodegib) | More about Fluorouracil topical | More about Imiquimod topical | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Erivedge has an average rating of 9.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fluorouracil topical has an average rating of 7.4 out of 10 from a total of 309 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 15% reported a negative effect. |
Imiquimod topical has an average rating of 6.9 out of 10 from a total of 455 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Erivedge side effects |
View all Fluorouracil topical side effects |
View all Imiquimod topical side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Erivedge prices |
View all Fluorouracil topical prices |
View all Imiquimod topical prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Carac, Efudex, Efudex Occlusion Pack, Fluoroplex, Tolak | Aldara, Zyclara | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
288 hours |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 62 drugs are known to interact with Erivedge:
|
A total of 6 drugs are known to interact with Fluorouracil topical:
|
A total of 6 drugs are known to interact with Imiquimod topical:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
January 30, 2012 |
July 29, 1970 |
February 27, 1997 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.